Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG35260

H4C1 Knockout A2780 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Ovary

  • Disease:

    Endometrioid carcinoma

The H4C1 Knockout A2780 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the A2780 ovarian carcinoma epithelial cell line. They enable loss-of-function studies of the H4C1 histone H4 gene, which is critical for nucleosome formation and chromatin integrity. H4C1 is regulated by E2F transcription factors and cyclin E/CDK2 and interacts with histones H2A, H2B, H3, and chromatin remodelers. This model is ideal for investigating chromatin biology, epigenetics, DNA damage response, and cancer cell biology. Assays such as Western blot, ChIP-qPCR, flow cytometry, and RNA-seq can be employed. Contact Ascent Research for support.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    A2780

    Sex of Donor

    Female

    Age

    Unknown

    Derived From Site

    In situ; Ovary

    Gene Name

    H4C1

    Gene Identifier

    NCBI Gene ID 8359

    Morphology

    Epithelial-like

    Growth Mode

    Adherent and suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The H4C1 Knockout A2780 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population for loss-of-function studies of the H4C1 gene in the A2780 human ovarian carcinoma epithelial line. This polyclonal pool preserves population-level heterogeneity and enables functional analysis without clonal artifacts. The cells are derived from the A2780 host and are suitable for investigating histone biology and chromatin dynamics.

The A2780 host cell line was established from an untreated ovarian carcinoma patient and is a widely used model for ovarian cancer research. These epithelial cells are characteristic of high-grade serous carcinoma and are extensively employed to study proliferation, drug sensitivity, and DNA repair. This clinically relevant background is ideal for exploring chromatin-related mechanisms in ovarian cancer.

H4C1 encodes replication-dependent histone H4, a core nucleosomal protein essential for chromatin structure and DNA packaging. Its expression is primarily regulated during S-phase by E2F transcription factors, NF-Y, Oct-1, HINFP, and cyclin E/CDK2. Histone H4 is assembled into nucleosomes with histones H2A, H2B, and H3, assisted by chaperones ASF1A, ASF1B, CAF-1, and HIRA, and remodeled by SWI/SNF and ISWI complexes. H4C1-mediated chromatin assembly governs global chromatin condensation and transcriptional regulation. Disruption of H4C1 impairs nucleosome formation, deregulates gene expression, and compromises DNA repair, leading to genomic instability.

In A2780 ovarian cancer cells, H4C1 knockout heightens genomic instability and disrupts cell cycle progression, offering a model to study chromatin dysfunction in oncogenic transformation. The polyclonal knockout allows assessment of collective effects on DNA damage response and epigenetic regulation, and facilitates exploration of therapeutic liabilities such as sensitivity to DNA-damaging agents or epigenetic inhibitors.

This knockout product supports research in epigenetics, chromatin biology, DNA damage response, cancer biology, and cell cycle regulation. Compatible assays include Western blotting for histone H4, RT-qPCR, ChIP-qPCR for histone modifications, immunofluorescence for chromatin structure, flow cytometry for cell cycle, RNA-seq, and apoptosis assays. For further details or customized requests, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)